مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.
Normal view MARC view ISBD view

MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. [electronic resource]

By:
  • Kesavan, Kamala
Contributor(s):
  • Lobel-Rice, Katherine
  • Sun, Weiyong
  • Lapadat, Razvan
  • Webb, Saiphone
  • Johnson, Gary L
  • Garrington, Timothy P
Producer: 20040402Description: 140-8 p. digitalISSN:
  • 0021-9541
Subject(s):
  • Animals
  • Blotting, Western
  • Cells, Cultured
  • Cytokines -- drug effects
  • Embryo, Mammalian
  • Enzyme Activation -- drug effects
  • Enzyme-Linked Immunosorbent Assay
  • Fibroblast Growth Factor 2 -- pharmacology
  • Fibroblasts -- drug effects
  • Fluorescent Antibody Technique
  • Gene Expression Regulation
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • MAP Kinase Kinase Kinase 2
  • MAP Kinase Kinase Kinases -- genetics
  • Mice
  • Mice, Knockout
  • Mitogen-Activated Protein Kinase Kinases -- drug effects
  • Mitogen-Activated Protein Kinases -- drug effects
  • Signal Transduction -- drug effects
  • Transcription Factor AP-1 -- physiology
  • Transcription, Genetic
Online resources:
  • Available from publisher's website
In: Journal of cellular physiology vol. 199
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Human epidermal growth factor receptor 2 regulates angiopoietin-2 expression in breast cancer via AKT and mitogen-activated protein kinase pathways.
    by Niu, Guilian
  • 2 Makers of angiogenesis in breast cancer.
    by Kiluk, John
  • 3 Changing paradigms in the treatment of endocrine tumors.
    by Lilienfeld, Howard
  • 4 Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter.
    by Lopez, Dayami
  • 5 Purified human chorionic gonadotropin induces apoptosis in breast cancer.
    by Lopez, Dayami
  • 6 New treatments and shifting paradigms in differentiated thyroid cancer management.
    by Carter, W Bradford
  • 7 Management of isolated Adrenal Lesions in Cancer Patients.
    by McLean, Kelly
  • 8 Paget's disease in the era of sentinel lymph node biopsy.
    by Laronga, Christine
  • 9 Mechanisms of HER2-induced endothelial cell retraction.
    by Carter, W Bradford
  • 10 HER2-positive male breast cancer with thyroid cancer: an institutional report and review of literature.
    by Bardhan, Pooja
  • 11 Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy.
    by Laronga, Christine
  • 12 Adenoid cystic carcinoma of the breast: a review of a single institution's experience.
    by Sarnaik, Amod A
  • 13 Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
    by Berg, Wendie A
  • 14 Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion.
    by Pimiento, Jose M
  • 15 Consequences of axillary ultrasound in patients with T2 or greater invasive breast cancers.
    by Lee, M Catherine
  • 16 Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.
    by Munster, Pamela N
  • 17 Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.
    by Greenberg, Caprice C
  • 18 Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer.
    by Hassett, Michael J
  • 19 A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.
    by Tafreshi, Narges K
  • 20 Invasive breast cancer.
    by Carlson, Robert W
Close

MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.

APA

Kesavan K., Lobel-Rice K., Sun W., Lapadat R., Webb S., Johnson G. L. & Garrington T. P. (20040402). MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. : Journal of cellular physiology.

Chicago

Kesavan Kamala, Lobel-Rice Katherine, Sun Weiyong, Lapadat Razvan, Webb Saiphone, Johnson Gary L and Garrington Timothy P. 20040402. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. : Journal of cellular physiology.

Harvard

Kesavan K., Lobel-Rice K., Sun W., Lapadat R., Webb S., Johnson G. L. and Garrington T. P. (20040402). MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. : Journal of cellular physiology.

MLA

Kesavan Kamala, Lobel-Rice Katherine, Sun Weiyong, Lapadat Razvan, Webb Saiphone, Johnson Gary L and Garrington Timothy P. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. : Journal of cellular physiology. 20040402.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site